Objective: The objective of the present study was to develop and validate a specific and sensitive analytical method, which separate the genotoxic impurity 4, 4'-bis (bromomethyl) biphenyl from valsartan antihypertensive drug substance using HPLC method. Methods:The development activity was conducted by HPLC with UV detector. The impurity was separated on Inertsil ODS 3V 250 x 4.6 mm, 5 µm analytical column with a mobile phase consisting of 5.5 pH buffer and acetonitrile with the gradient program at a flow rate 1.0 ml/min. The effluent was detected using UV detector attached with HPLC system at 275 nm meanwhile column temperature and injection volume was maintained to 35 °C and 50 μl respectively. Acetonitrile was selected as diluent for performing the experiment.Results: Whole experiment and validation process was performed as per the ICH guideline. The LOD and LOQ value were found to be 0.153 µg/g and 0.463 µg/g respectively, while accuracy results were well in the range 97.62 to 104.59%. The linearity curve showed a correlation coefficient of 0.9994 and method was very sensitive. Conclusion:From validation data, it was confirmed that the developed method is specific, sensitive, linear, precise and accurate for the determination of 4, 4'-bis (bromomethyl) biphenyl genotoxic impurity in valsartan drug substances.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.